William R. MSgt. USAF TOPOR TOPOR, William R., MSgt. USAF (Age 82) “I will meet you when my chores are done” Love, me. by Collin Raye After fighting a valiant four year battle with Multiple Myeloma, along with the loss of his beloved wife, Carole, Bill passed away peacefully at Holy Family Hospital on November […]

Immunotherapy for treating multiple myeloma Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses immunotherapeutic interventions to treat multiple myeloma. Dr Raje highlights allogeneic CAR T-cells that are currently in clinical trials. Belantamab mafodotin, an immunoconjugate targeting B-cell maturation antigen (BCMA), as used in the DREAMM trials (NCT04126200/NCT03525678), is now approved by the FDA and […]

Galatia woman fights cancer with SIH, Siteman doctors [unable to retrieve full-text content] She missed several calls before receiving a voicemail from her doctor asking … Vij told Jenkins that her multiple myeloma was Stage 3 of three stages.Published at Sat, 12 Dec 2020 01:07:30 +0000

Clinical management of plasma cell leukemia: an update Francesca Gay, MD, PhD, of the University of Turin, Turin, Italy, briefly describes the major differences in the clinical presentation of plasma cell leukemia (PCL) and multiple myeloma (MM), including age, severity and risk of chromosomal abnormalities, despite both being plasma cell neoplasms. Dr Gay goes on […]

Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an … SUZHOU, China and ROCKVILLE, MD, Dec. 9, 2020 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced updates on the clinical development of the […]

Health: Many cancer survivors at higher risk of dying from like flu for a DECADE after diagnosis Many cancer survivors are at a higher risk of hospitalisation and dying from influenza for at least a decade after their diagnosis, a study has found. British experts analysed the medical records of more than 630,000 people in the […]

Monoclonal antibodies for multiple myeloma The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided patients with hematologic malignancies and benign hematologic disorders with enhanced outcomes and improved quality of life. The 2016 Great Debates & Updates in Hematologic Malignancies conference, held April 1-2 in New […]

(Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society … Karyopharm Presents XPOVIO® (Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society of Hematology 2020 Annual Meeting — Pomalyst®, Kyprolis® and Revlimid® Arms of the Phase 1b/2 STOMP Study Evaluating Once Weekly XPOVIO with Low-Dose Dexamethasone Combinations […]

Andy, multiple myeloma survivor Andy lost his first wife to multiple myeloma, then twelve years later, Andy himself was struck by the same disease. Discover how every donation makes a difference at http://www.lls.org

Pfizer Reports Positive Phase II Trial of BRAF, MEK Inhibitor Combo in Multiple Myeloma NEW YORK – In a small Phase II trial evaluating Pfizer’s encorafenib (Braftovi) and binimetinib (Mektovi), the majority of heavily pretreated, refractory multiple myeloma patients with BRAF V600 mutations saw their tumors shrink on the combination regimen, researchers reported at the American […]